Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
Public Employees Retirement System of Ohio Decreases Position in ChemoCentryx Inc (NASDAQ:CCXI)
09:54am, Wednesday, 23'rd Sep 2020
Public Employees Retirement System of Ohio cut its position in ChemoCentryx Inc (NASDAQ:CCXI) by 36.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 27,655 s
Global Hidradenitis Suppurativa (HS) Market Insights, Epidemiology and Market Forecasts, 2017-2019 & 2020-2030 - ResearchAndMarkets.com
12:00am, Wednesday, 23'rd Sep 2020
The
Bank of New York Mellon Corp Has $12.19 Million Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
04:42am, Thursday, 17'th Sep 2020
Bank of New York Mellon Corp grew its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 5.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
ChemoCentryx Inc (CCXI) Q2 2020 Earnings Call Transcript
08:31pm, Tuesday, 11'th Aug 2020
CCXI earnings call for the period ending June 30, 2020.
Tencent’s China Literature Crashes to $465 Million Loss
02:00pm, Tuesday, 11'th Aug 2020
China Literature, which is both China’s leading online bookstore and owner of one of the country’s top TV producers, swung from profits of $55 million a year ago to net losses of $465 million in t
Analysts Are Bullish on These Healthcare Stocks: ChemoCentryx (CCXI), ICU Medical (ICUI) - Markets
12:30pm, Tuesday, 11'th Aug 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ChemoCentryx (CCXI
ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates
09:45pm, Monday, 10'th Aug 2020
ChemoCentryx (CCXI) delivered earnings and revenue surprises of 185.29% and 494.95%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights
08:05pm, Monday, 10'th Aug 2020
\-- U.S. New Drug Application (NDA) submitted for avacopan in ANCA-associated vasculitis --\-- Balance sheet bolstered with $325.7 million in net proceeds from June follow-on offering; total cash, ca
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Advisor Group Holdings Inc. Makes New Investment in ChemoCentryx Inc (NASDAQ:CCXI)
06:34am, Wednesday, 05'th Aug 2020
Advisor Group Holdings Inc. purchased a new position in ChemoCentryx Inc (NASDAQ:CCXI) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commi
Bio-Techne Corp (TECH) Q4 2020 Earnings Call Transcript | The Motley Fool
07:31pm, Tuesday, 04'th Aug 2020
TECH earnings call for the period ending June 30, 2020.
ChemoCentryx to Present at Two Upcoming Investor Conferences
12:30pm, Tuesday, 04'th Aug 2020
MOUNTAIN VIEW, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two up
ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020
12:30pm, Monday, 03'rd Aug 2020
MOUNTAIN VIEW, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2020 financial results will be released after market clos
Earnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to Decline
04:31pm, Monday, 27'th Jul 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How Much is ChemoCentryx's (NASDAQ:CCXI) CEO Getting Paid?
10:37am, Tuesday, 21'st Jul 2020
This article will reflect on the compensation paid to Thomas Schall who has served as CEO of ChemoCentryx, Inc...
